Imagine waking up to this: KERX from 5.25 to .77 overnight. LOL!!!! InPlay: Keryx Biopharma announces that SUN-MICRO Ph. 3 clinical trial fails to meet primary efficacy endpoint Briefing.com(Mon 8:07am)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.